|
|
| Line 1: |
Line 1: |
| __NOTOC__
| | #redirect:[[Amikacin sulfate]] |
| {{Amikacin}}
| |
| '''''For patient information, click <u>[[Amikacin Sulfate Injection (patient information)|here]]'''''</u>.
| |
| | |
| {{CMG}}
| |
| | |
| ==Overview==
| |
| | |
| Amikacin is an [[aminoglycoside]] [[antibiotic]] used to treat different types of [[bacteria|bacterial]] [[infection]]s. Amikacin is most often used for treating severe, hospital-acquired infections with [[multidrug resistance|multidrug resistant]] [[Gram negative]] bacteria such as ''[[Pseudomonas aeruginosa]]'', ''[[Acinetobacter]]'', and ''[[Enterobacter]]''. Amikacin may be combined with a [[beta-lactam]] antibiotic for [[empiric therapy]] for [[febrile neutropenia]].
| |
| | |
| ==Category==
| |
| | |
| Aminoglycoside
| |
| | |
| ==US Brand Names==
| |
| | |
| AMIKACIN SULFATE<sup>®</sup>, AMIKIN<sup>®</sup>
| |
| | |
| ==FDA Package Insert==
| |
| | |
| '''[[Amikacin description|Description]]'''
| |
| '''| [[Amikacin clinical pharmacology|Clinical Pharmacology]]'''
| |
| '''| [[Amikacin microbiology|Microbiology]]'''
| |
| '''| [[Amikacin indications and usage|Indications and Usage]]'''
| |
| '''| [[Amikacin contraindications|Contraindications]]'''
| |
| '''| [[Amikacin warnings and precautions|Warnings and Precautions]]'''
| |
| '''| [[Amikacin adverse reactions|Adverse Reactions]]'''
| |
| '''| [[Amikacin overdosage|Overdosage]]'''
| |
| '''| [[Amikacin dosage and administration|Dosage and Administration]]'''
| |
| '''| [[Amikacin how supplied|How Supplied]]'''
| |
| '''| [[Amikacin labels and packages|Labels and Packages]]'''
| |
| | |
| ==Mechanism of Action==
| |
| | |
| Amikacin works by binding to the bacterial [[30S]] [[ribosome|ribosomal]] subunit, causing misreading of [[mRNA]] and leaving the bacterium unable to synthesize [[protein]]s vital to its growth.
| |
| | |
| ==References==
| |
| {{Reflist|2}}
| |
| | |
| [[Category:Antibiotics]]
| |
| [[Category:Wikinfect]]
| |